Boai NKY Pharmaceuticals Ltd (300109) — Capital Reinvestment Ratio
Boai NKY Pharmaceuticals Ltd (300109) has a Capital Reinvestment Ratio of 0.30x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥139.46 Million) in capital expenditures (CN¥41.41 Million). Check 300109 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Boai NKY Pharmaceuticals Ltd Capital Reinvestment Ratio (2007–2025)
This chart tracks Boai NKY Pharmaceuticals Ltd's Capital Reinvestment Ratio across 18 annual periods. For the full cash flow conversion analysis, see how efficiently does Boai NKY Pharmaceuticals Ltd generate cash.
Annual Capital Reinvestment Ratio for Boai NKY Pharmaceuticals Ltd (2007–2025)
Year-by-year Capital Reinvestment Ratio for Boai NKY Pharmaceuticals Ltd from 2007 to 2025. See Boai NKY Pharmaceuticals Ltd (300109) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.65x | CN¥338.11 Million | CN¥220.42 Million | ▼ -39.2% |
| 2024 | 1.07x | CN¥256.03 Million | CN¥274.68 Million | ▲ +38.6% |
| 2023 | 0.77x | CN¥488.25 Million | CN¥377.88 Million | ▼ -26.7% |
| 2022 | 1.06x | CN¥251.77 Million | CN¥266.00 Million | ▼ -79.9% |
| 2021 | 5.26x | CN¥43.44 Million | CN¥228.32 Million | ▲ +1313.4% |
| 2020 | 0.37x | CN¥266.87 Million | CN¥99.24 Million | ▼ -79.2% |
| 2019 | 1.79x | CN¥79.64 Million | CN¥142.35 Million | ▼ -29.9% |
| 2018 | 2.55x | CN¥48.81 Million | CN¥124.37 Million | ▼ -6.8% |
| 2017 | 2.73x | CN¥47.28 Million | CN¥129.23 Million | ▲ +543.7% |
| 2016 | 0.42x | CN¥114.14 Million | CN¥48.47 Million | ▼ -32.7% |
| 2015 | 0.63x | CN¥64.12 Million | CN¥40.48 Million | ▼ -37.6% |
| 2014 | 1.01x | CN¥46.60 Million | CN¥47.11 Million | ▼ -34.0% |
| 2013 | 1.53x | CN¥23.17 Million | CN¥35.47 Million | ▼ -65.3% |
| 2012 | 4.41x | CN¥20.65 Million | CN¥90.96 Million | ▼ -83.4% |
| 2011 | 26.46x | CN¥3.94 Million | CN¥104.29 Million | ▲ +1144.2% |
| 2010 | 2.13x | CN¥10.05 Million | CN¥21.38 Million | ▲ +140.5% |
| 2009 | 0.88x | CN¥28.57 Million | CN¥25.27 Million | ▲ +77.3% |
| 2007 | 0.50x | CN¥9.56 Million | CN¥4.77 Million | — |